Dr Maja Petkovic commented “The first FDA approved treatments were CAR-T cells directed against the B cell protein CD19. This ...

The challenge of managing relapsed or refractory B-cell malignancies continues to thwart the efforts of oncologists and ...

A new study on rheumatoid arthritis has found that while individuals look and feel healthy in the years before their symptoms ...

Researchers have harnessed the power of artificial intelligence to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens.

Professor Alexander Hoffmann and Genhong Cheng from University of California, Los Angeles, jointly with Professor David ...

“However, there are numerous studies that have shown that individuals can have abnormal blood tests such as anti-CCP for on ...

Monte Rosa Therapeutics stock surged after expanding its Novartis partnership. Click here to learn about their innovative ...

In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.

A tragic RSV vaccine trial in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...

Trial investigator Emma Guttman, MD, PhD, chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, here explains why targeting the OX40-OX40 ligand pathway is so exciting ...